Revenue: The sum of all revenue fields included for a company's operating activities.
Nuvation Bio Inc. (NUVB) had Revenue of $3.08M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
$3.08M |
$-53.24M |
|
$2.09M |
|
$0.99M |
|
$62.09M |
|
$-59.00M |
|
$5.77M |
|
$-53.24M |
|
$-53.24M |
|
$-53.24M |
|
$-53.24M |
|
$-53.24M |
|
$-53.24M |
|
$-59.00M |
|
$-58.69M |
|
338.61M |
|
338.61M |
|
$-0.16 |
|
$-0.16 |
|
| Balance Sheet Financials | |
$475.57M |
|
$0.56M |
|
$16.92M |
|
$492.49M |
|
$52.77M |
|
-- |
|
$20.26M |
|
$73.03M |
|
$419.46M |
|
$415.05M |
|
$419.46M |
|
339.84M |
|
| Cash Flow Statement Financials | |
$-42.63M |
|
$54.18M |
|
$0.55M |
|
$35.72M |
|
$47.98M |
|
$12.25M |
|
$7.85M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.01 |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
32.10% |
|
-1913.23% |
|
-1913.23% |
|
-- |
|
-1726.20% |
|
-1726.20% |
|
$-42.70M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
149.57 |
|
0.56 |
|
159.40 |
|
-12.69% |
|
-12.83% |
|
-10.81% |
|
-12.69% |
|
$1.23 |
|
$-0.13 |
|
$-0.13 |
|